Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Peroxisome Proliferator-Activated Receptor Gamma (PPARG2) rs3856806 Gene Polymorphism as a Risk Factor for Type 2 Diabetes Mellitus
Saved in:
| Published in: | Global Health Management Journal (GHMJ) |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Peroxisome Proliferator-Activated Receptor Gamma (PPARG2) rs3856806 Gene Polymorphism as a Risk Factor for Type 2 Diabetes Mellitus
- In Silico Structural Analysis of Malaria - Associated Single Nucleotide Polymorphisms in Human Genes TLR4, ICAM1, and IL22
- The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational Study
- Steroidal Mineralocorticoid Receptor Antagonist Side Effects and Reasons for Discontinuation: A Patient Survey (RELICS-PS)
- Treatment Patterns, Adverse Events, and Clinical Outcomes with Steroidal Mineralocorticoid Receptor Antagonists: A Retrospective Analysis of Administrative Claims Data (RELICS)
- An Age‐Adapted Co‐Design Methodology for Community Health Research Involving Older Adults With Type 2 Diabetes
- Reviewer Acknowledgements and Highlights: Equity, Resilience, and the Human Dimensions of Health – GHMJ (Global Health Management Journal), Volume 9, Number 2, 2026